LYON JOSEPH DOUGLAS (Chief Accounting Officer) sold 21.9% of their position (1.54K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $175.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/5/2026ACC: 0001193125-26-335605
Officer· Chief Accounting Officer
Since Jul 2020
-1.54K
Net shares
Net seller
$175.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.54K
Price / share
$114.16
Trade value
$175.81K
% of position
21.9%
8/3/2026
7.04K→5.50K
Total
Net shares
−1.54K
Net value
-$175.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −1.54K | $114.16 | $175.81K | 21.9% | 7.04K | 5.50K |
| Total | −1.54K | -$175.81K | ||||||
Derivative Transactions0
No derivative transactions reported